Researchers check for withdrawal from agitation drug
NCT ID NCT06041646
Summary
This study looked at what happens when people stop taking the medication Igalmi after using it for a week to treat severe agitation. It involved 29 adults with schizophrenia or bipolar disorder who took the drug as needed for agitation over 7 days, then were monitored for 3 days without it. The main goal was to see if stopping the medication caused withdrawal symptoms or if the drug became less effective with repeated use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BioXcel Clinical Research Site
Little Rock, Arkansas, 72211, United States
-
BioXcel Clinical Research Site
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.